NYXH - Nyxoah S.A.

Valuation of Nyxoah S.A.(NYXH), Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solut

Nyxoah S.A.

NYXH

NASDAQ

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

10.62 USD

0.135 (1.27%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Apr 24, 2024 4:00 PM

Share Price on Valuation Date

$10.62

Stock Beta

0.477

Shares Outstanding

28662000

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.